[HTML] cell.com

[HTML][HTML] Human ES-and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice

R Darabi, RW Arpke, S Irion, JT Dimos, M Grskovic… - Cell stem cell, 2012 - cell.com
A major obstacle in the application of cell-based therapies for the treatment of
neuromuscular disorders is obtaining the appropriate number of stem/progenitor cells to …
被引用次数：499 相关文章

Human ES-and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice.

R Darabi, RW Arpke, S Irion, JT Dimos, M Grskovic… - Cell Stem …, 2012 - europepmc.org
SUMMARY A major obstacle in the application of cell-based therapies for the treatment of
neuromuscular disorders is obtaining the appropriate number of stem/progenitor cells to …
[HTML] nih.gov

[HTML][HTML] Human ES-and iPS-Derived Myogenic Progenitors Restore Dystrophin and Improve Contractility upon Transplantation in Dystrophic Mice

R Darabi, RW Arpke, S Irion, JT Dimos, M Grskovic… - Cell Stem …, 2012 - ncbi.nlm.nih.gov
SUMMARY A major obstacle in the application of cell-based therapies for the treatment of
neuromuscular disorders is obtaining the appropriate number of stem/progenitor cells to …

Human ES-and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice

R Darabi, RW Arpke, S Irion, JT Dimos… - Cell stem …, 2012 - pubmed.ncbi.nlm.nih.gov
A major obstacle in the application of cell-based therapies for the treatment of
neuromuscular disorders is obtaining the appropriate number of stem/progenitor cells to …

Human ES-and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice

R Darabi, RW Arpke, S Irion, JT Dimos, M Grskovic… - Cell Stem …, 2012 - experts.umn.edu
A major obstacle in the application of cell-based therapies for the treatment of
neuromuscular disorders is obtaining the appropriate number of stem/progenitor cells to …

[引用][C] Human ES-and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice

R DARABI, RW ARPKE, S IRION, JT DIMOS… - Cell stem …, 2012 - pascal-francis.inist.fr
Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve
Contractility upon Transplantation in Dystrophic Mice CNRS Inist Pascal-Francis CNRS …
[HTML] sciencedirect.com

[HTML][HTML] Human ES-and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice

R Darabi, RW Arpke, S Irion, JT Dimos, M Grskovic… - Cell Stem Cell, 2012 - Elsevier
A major obstacle in the application of cell-based therapies for the treatment of
neuromuscular disorders is obtaining the appropriate number of stem/progenitor cells to …
[PDF] wesleyan.edu

[PDF][PDF] Human ES-and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice

R Darabi, RW Arpke, S Irion, JT Dimos… - Cell Stem …, 2012 - sdevoto.web.wesleyan.edu
SUMMARY A major obstacle in the application of cell-based therapies for the treatment of
neuromuscular disorders is obtaining the appropriate number of stem/progenitor cells to …

Human ES-and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice

R Darabi, RW Arpke, S Irion, JT Dimos, M Grskovic… - Cell Stem Cell, 2012 - infona.pl
A major obstacle in the application of cell-based therapies for the treatment of
neuromuscular disorders is obtaining the appropriate number of stem/progenitor cells to …

[引用][C] Human ES-and iPS-derived myogenic progenitors restore dystrophin and improve contractility upon transplantation in dystrophic mice

R DARABI - Cell Stem Cell, 2012 - cir.nii.ac.jp
Human ES- and iPS-derived myogenic progenitors restore dystrophin and improve
contractility upon transplantation in dystrophic mice | CiNii Research CiNii 国立情報学 …